Journal of Korean Society of Health-System Pharmacists

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN    pISSN

Table. 2.

Table. 2.

Baseline characteristics between pre-DMR and post-DMR

pre-DMR (n=24,999) post-DMR (n=22,471) P-Value
Gender (n,%) Female 12,717 (50.9%) 11,588 (51.6%) 0.128
Male 12,282 (49.1%) 10,883 (48.4%)
Age (yrs, mean±SD) 49.4±23.2 52.0±21.1 <0.01
eGFR (n, mg/dL) <15 434 389 0.322
≥15 and <30 204 207
≥30 and <45 515 414
≥45 and <60 1,500 1,376
60≥ 22,346 20,085
Diagnosis (n,%) Cancer 6,599 (26.4%) 6,884 (30.6%) <0.01
Major internal disease* 6,522 (26.1%) 5,350 (23.8%)
Major surgical disease 2,876 (11.5%) 2,818 (12.5%)
Others 9,002 (36.0%) 7,419 (33.0%)
DRPperceived by pharmacist (No. of drugs with DRP/No. of discharges with DRP, n,%) 607(460) (1.8%) 902(688) (3.1%) <0.01
Hospital length of stay (days, mean±SD) 6.3±10.5 6.2±10.3 0.687
Number of discharge drugs (n, mean±SD) 4.99±3.2 4.95±3.3 0.293

SD, standard deviation; eGFR, estimated glomerular filtration rate

* Diseases of the circulatory system, digestive system and respiratory system

Diseases of the musculo-skeletal system and connective tissue or diseases of injury, poisoning and certain other consequences of external causes

The proportion and p-value were calculated using No. of discharge

J. Kor. Soc. Health-syst. Pharm. 2021;38:306-18 https://doi.org/10.32429/jkshp.2021.38.3.002
© 2021 J. Kor. Soc. Health-syst. Pharm.